NCT03418610 is a Phase 4 clinical trial of Azelaic Acid foam 15% in Rosacea, Papulopustular, sponsored by Clinical Research Center of the Carolinas.

Who is sponsoring NCT03418610?

NCT03418610 is sponsored by Clinical Research Center of the Carolinas.

What drugs are being tested in NCT03418610?

Interventions in NCT03418610: Azelaic Acid foam 15%.

What condition does NCT03418610 study?

NCT03418610 studies Rosacea, Papulopustular.

Is NCT03418610 still recruiting?

NCT03418610 is currently completed. Last updated 24 July 2019.

Last reviewed 2019-07-24 · How we verify

NCT03418610

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea

Completed Phase 4 Last updated 24 July 2019

What this trial tests

Phase 4 trial testing Azelaic Acid foam 15% in Rosacea, Papulopustular in 5 participants. Completed in 9 January 2019.

Timeline

6 December 2017

Primary endpoint
9 January 2019

9 January 2019

Quick facts

Lead sponsor	Clinical Research Center of the Carolinas
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	5
Start date	6 December 2017
Primary completion	9 January 2019
Estimated completion	9 January 2019
Sites	1 location across United States

Drugs / interventions tested

Azelaic Acid foam 15% — full drug profile →

Conditions studied

Rosacea, Papulopustular — all drugs for Rosacea, Papulopustular →

Sponsor

Clinical Research Center of the Carolinas

Who can join

18 and older, any sex, with Rosacea, Papulopustular. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research study is being performed to evaluate the photographic evidence of the efficacy and tolerability of Azelaic Acid Foam 15% in the treatment of papulopustular rosacea.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Rosacea, Papulopustular

Currently open trials in the same condition.

NCT06801717 — Rosacea Radiofrequency Microneedling · NA · recruiting

Other Clinical Research Center of the Carolinas trials

Trials by the same sponsor.

NCT04008784 — Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomi · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03418610 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Clinical Research Center of the Carolinas
Last refreshed: 24 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03418610.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing